The Return Of The “Specialty” Drug Pricing Debate In The US

 
• By Michael McCaughan

Pharma has been almost wholly successful in shifting the ground in the US drug pricing debate away from high-cost “specialty” products and towards the large gap between list and net prices, with the most intense focus on older medicines like insulin. What happens when the debate shifts back?

Foot pedals are levers of forklift car that are activated by the driver's feet to control certain aspects of the vehicle's operation brake pedal Car accelerator controls. - Image

More from Pricing Debate

More from Market Access